Systemic Sclerosis (SSc) Vasculopathy: Improved Clinical Monitoring and Treatment

NCT02530996 · clinicaltrials.gov ↗

PHASE1,PHASE2

Phase

COMPLETED

Status

12

Enrollment

FED

Sponsor class

Conditions

Rheumatologic Disease

Interventions

DRUG: BH4
DIAGNOSTIC_TEST: Vasculopathy assessment
DRUG: Placebo

Sponsor

VA Office of Research and Development